deltatrials
Active Not Recruiting PHASE3 INTERVENTIONAL 3-arm NCT02845882

LBL-2016 for Children or Adolescents in China

Modified BFM (Berlin-Frankfurt-Munster)Backbone Therapy for Chinese Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma

Sponsor: Children's Cancer Group, China

Conditions Lymphoblastic Lymphoma
Interventions 6-mercaptopurine,Methotrexate Dexamethasone, Cytarabine, Etoposide, Pegylated-asparaginase Dexamethasone, Vindesine, Methotrexate, Ifosfamide, Daunorubicin, Pegylated-asparaginase Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Doxorubicin, 6-mercaptopurine Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Methotrexate Methotrexate, 6-mercaptopurine Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
Updated 16 times since 2017 Last updated: Feb 11, 2025 Started: Jan 31, 2016 Primary completion: Dec 31, 2023 Completion: Dec 31, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Lymphoblastic Lymphoma, this trial is ongoing. The trial is conducted by Children's Cancer Group, China and has accumulated 16 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Jul 2019 · 6 months · monthly snapshot~Jul 2019 – ~Aug 2020 · 13 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Apr 2022 · 7 months · monthly snapshot~Apr 2022 – ~Oct 2023 · 18 months · monthly snapshot~Oct 2023 – ~Mar 2024 · 5 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – present · 18 months · monthly snapshot

Change History

16 versions recorded

  1. Mar 2025 — Present [monthly]

    Active Not Recruiting PHASE3

  2. Sep 2024 — Mar 2025 [monthly]

    Active Not Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  4. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

  5. Oct 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE3

▶ Show 11 earlier versions

  1. Apr 2022 — Oct 2023 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  2. Sep 2021 — Apr 2022 [monthly]

    Recruiting PHASE3

  3. Feb 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  4. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  5. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  6. Jul 2019 — Aug 2020 [monthly]

    Recruiting PHASE3

    Phase: PHASE2_PHASE3 → PHASE3

  7. Jan 2019 — Jul 2019 [monthly]

    Recruiting PHASE2_PHASE3

  8. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE2_PHASE3

  9. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

  10. Jun 2017 — Dec 2017 [monthly]

    Recruiting PHASE2_PHASE3

  11. Jan 2017 — Jun 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Cancer Group, China
  • Children's Hospital of Soochow University
  • Nanjing Children's Hospital
  • Qilu Hospital of Shandong University
  • Shanghai Children's Medical Center
  • Tianjin Medical University Cancer Institute and Hospital
  • Tongji Hospital
  • West China Second University Hospital
  • Xiangya Hospital of Central South University
Data source: Children's Cancer Group, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations